Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus
There are no files associated with this record.
| Title | Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus |
|---|---|
| Author | Ryan, Charlotte; Zaitsev, Viateslav; Tindal, David James; Dyason, Jeffrey Clifford; Thomson, Robin Joy; Alymova, Irina; Porter, Allen; von Itzstein, Mark; Taylor, Garry |
| Journal Name | Glycoconjugate Journal |
| Year Published | 2006 |
| Place of publication | United States |
| Publisher | Springer |
| Abstract | Viruses of the Paramyxoviridae family are the leading cause of respiratory disease in children. The human parainfluenza viruses (hPIV) are members of the Paramyxovirinae subfamily, which also includes mumps virus, Newcastle disease virus (NDV), Sendai virus (SV) and simian type 5 virus (SV5). On the surface of these viruses is the glycoprotein hemagglutinin-neuraminidase (HN), which is responsible for cell attachment, promotion of fusion and release of progeny virions. This multifunctional nature of HN makes it an attractive target for the development of inhibitors as a treatment for childhood respiratory diseases. Here we report the crystal structure of NDV HN in complex with a derivative of 2-deoxy-2,3-dehydro-Nacetylneuraminic acid, Neu5Ac2en, that has a functional group designed to occupy a large conserved binding pocket around the active site. The purpose of this study was to examine the effect of a bulky hydrophobic group at the O4 position of Neu5Ac2en, given the hydrophobic nature of the binding pocket. This derivative, with a benzyl group added to the O4 position of Neu5Ac2en, has an IC50 of ∼10 μM in a neuraminidase assay against hPIV3 HN. The IC50 value of the parent compound, Neu5Ac2en, in the same assay is ∼25 μM. These results highlight the striking difference between the influenza neuraminidase and paramyxovirus HN active sites, and provide a platform for the development of improved HN inhibitors. |
| Peer Reviewed | Yes |
| Published | Yes |
| Alternative URI | http://dx.doi.org/10.1007/s10719-006-5446-8 |
| Volume | 23 |
| Page from | 135 |
| Page to | 141 |
| ISSN | 0282-0080 |
| Date Accessioned | 2007-02-23 |
| Date Available | 2010-08-26T07:35:43Z |
| Language | en_AU |
| Research Centre | Institute for Glycomics |
| Faculty | Institute for Glycomics |
| Subject | PRE2009-Enzymes |
| URI | http://hdl.handle.net/10072/13715 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1 |
Please use this identifier to cite this record: http://hdl.handle.net/10072/13715
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top